Real-world evidence (RWE) derived from robust, real-world data is becoming the engine that drives healthcare innovation. From COVID-19 mitigation, to post-market surveillance, to clinical trial design, RWE holds the promise to accelerate time-to-market and inform personalized medicine. Despite the opportunity, the health data landscape is still in its infancy. How are companies generating RWE today? What are some of the short- and long-term hurdles to unlocking the true power of RWE?
View this on-demand webinar for an in-depth discussion with RWE experts from Frost & Sullivan, Pfizer, and Komodo Health to learn about:
- The current RWE market landscape
- The challenges of managing deep, broad data sets to extract RWE insights
- How software built on real-world data can remove obstacles to data feasibility and timely insight
.png)
